Real Estate & Construction » Real Estate | Beijing Centergate Technologies

Beijing Centergate Technologies | Cash Flow

Fiscal year is January-December. All values CNY Thousands.
2013
2014
2015
2016
2017
2018
Net Income before Extraordinaries
210,528.90
13,697.00
154,482.00
45,030.60
43,564.80
120,880.30
Depreciation, Depletion & Amortization
37,380.20
41,218.40
39,134.30
51,592.50
66,449.50
125,667.30
Other Funds
37,944.40
67,955.80
84,823.00
66,024.40
588,080.80
7,660.40
Funds from Operations
118,242.60
83,826.90
33,201.60
194,635.70
182,717.90
251,026.20
Changes in Working Capital
382,665.00
461,131.10
47,606.40
226,314.90
26,474.30
49,213.80
Net Operating Cash Flow
500,907.60
377,304.20
14,404.80
31,679.30
156,243.60
201,812.40
Capital Expenditures
37,181.00
69,570.20
72,904.80
55,854.20
128,238.10
Sale of Fixed Assets & Businesses
438.70
145.40
370,045.00
31.20
949.40
Purchase/Sale of Investments
-
9,811.90
-
-
-
Net Investing Cash Flow
26,742.30
110,521.70
267,310.60
239,312.70
147,574.20
Issuance/Reduction of Debt, Net
72,700.00
135,400.00
75,300.00
215,763.20
316,197.30
Net Financing Cash Flow
110,644.40
67,444.20
160,123.00
237,068.80
282,799.80
Net Change in Cash
363,520.90
420,381.70
92,782.80
33,923.10
291,469.20
Free Cash Flow
463,726.60
446,874.40
87,309.60
87,533.50
28,005.50
Deferred Taxes & Investment Tax Credit
13,897.60
402.60
10,733.60
3,093.90
433.30
3,181.80
Net Assets from Acquisitions
-
-
29,829.70
183,489.70
20,285.50
Other Sources
10,000.00
-
-
-
-
Change in Capital Stock
-
-
-
87,330.00
10,916.20
Other Uses
-
31,285.00
-
-
-

About Beijing Centergate Technologies

View Profile
Address
Shenzhou Building
Beijing Beijing 100081
China
Employees -
Website http://www.centek.com.cn
Updated 07/08/2019
Beijing Centergate Technologies (Holding) Co., Ltd. engages in the development, management and investment of real estate. It operates business through four business segments-biomedical, personal care products, real estate & construction and other business. It mainly engages in the biomedical product preparation including tablets, injections, APIs, capsule, oral solution, granules, narcotic drugs, personal care products, manufacture and sale of commercial concrete and cement products.